IN172885B - - Google Patents
Info
- Publication number
- IN172885B IN172885B IN83BO1991A IN172885B IN 172885 B IN172885 B IN 172885B IN 83BO1991 A IN83BO1991 A IN 83BO1991A IN 172885 B IN172885 B IN 172885B
- Authority
- IN
- India
- Prior art keywords
- antibody
- agent
- target site
- toothpaste
- cosmetic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6815—Enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6835—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment the modifying agent being an antibody or an immunoglobulin bearing at least one antigen-binding site
- A61K47/6883—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy
- A61K47/6885—Polymer-drug antibody conjugates, e.g. mitomycin-dextran-Ab; DNA-polylysine-antibody complex or conjugate used for therapy the conjugate or the polymer being a starburst, a dendrimer, a cascade
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/59—Mixtures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/94—Involves covalent bonding to the substrate
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Detergent Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909006327A GB9006327D0 (en) | 1990-03-21 | 1990-03-21 | Delivery of therapeutic agents |
GB909021671A GB9021671D0 (en) | 1990-10-05 | 1990-10-05 | Delivery of agents |
Publications (1)
Publication Number | Publication Date |
---|---|
IN172885B true IN172885B (es) | 1993-12-25 |
Family
ID=26296814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN83BO1991 IN172885B (es) | 1990-03-21 | 1991-03-21 |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0453097B1 (es) |
JP (1) | JP3098050B2 (es) |
AT (1) | ATE131069T1 (es) |
AU (1) | AU641736B2 (es) |
BR (1) | BR9101117A (es) |
CA (1) | CA2038578C (es) |
DE (1) | DE69115104T2 (es) |
ES (1) | ES2082132T3 (es) |
IN (1) | IN172885B (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL1009834C2 (nl) * | 1998-08-10 | 2000-02-11 | Stanislaus Laurens Johan Woute | Antistoffen voor toepassing in de gerichte en tijdelijke behandeling van mens en dier. |
ATE292475T1 (de) * | 1999-09-16 | 2005-04-15 | Unilever Nv | Abgabesystem für ein mittel gegen schuppen |
US7807141B2 (en) | 2003-09-08 | 2010-10-05 | E.I. Du Pont De Nemours And Company | Peptide-based oral care surface reagents for personal care |
US7585495B2 (en) | 2003-09-08 | 2009-09-08 | E. I. Du Pont De Nemours And Company | Method for identifying shampoo-resistant hair-binding peptides and hair benefit agents therefrom |
US7285264B2 (en) | 2003-09-08 | 2007-10-23 | E.I. Du Pont De Nemours And Company | Peptide-based body surface coloring reagents |
US7220405B2 (en) | 2003-09-08 | 2007-05-22 | E. I. Du Pont De Nemours And Company | Peptide-based conditioners and colorants for hair, skin, and nails |
US7736633B2 (en) | 2005-09-28 | 2010-06-15 | E.I. Du Pont De Nemours And Company | Method for enhancing effects of colorants and conditioners |
EP2315569B1 (en) | 2008-06-13 | 2016-09-14 | Oragenics, Inc. | Use of hydrogen peroxide-producing bacteria for tooth whitening |
WO2010114638A1 (en) | 2009-03-30 | 2010-10-07 | E. I. Du Pont De Nemours And Company | Peptide-based tooth whitening reagents |
MX2013006994A (es) | 2010-12-20 | 2013-07-29 | Du Pont | Generacion enzimatica de peracidos para usarse en productos para el cuidado oral. |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1433593A (en) * | 1972-06-09 | 1976-04-28 | Royal College Of Surgeons | Conjugates |
DD249977A1 (de) * | 1986-06-10 | 1987-09-23 | Magdeburg Medizinische Akad | Verfahren zur qualitativen oder quantitativen bestimmung von str. b iii oder 1a str. b iii |
EP0271180B2 (en) * | 1986-08-18 | 1997-06-18 | The Dow Chemical Company | Starburst conjugates |
US4943525A (en) * | 1987-11-02 | 1990-07-24 | Bioventures, Inc. | Simultaneous immunoassay for the determination of antigens and antibodies |
SE461570B (sv) * | 1988-06-06 | 1990-03-05 | Rama Bio Link Ab | Farmaceutiskt preparat och konjugat av en baktericid och en antikropp |
WO1990003185A1 (en) * | 1988-09-28 | 1990-04-05 | Ideon Corporation | Combination enzyme immunotherapeutics |
WO1991000112A1 (en) * | 1989-06-30 | 1991-01-10 | Brunswick Corporation | Antibody-lactate oxidase conjugates |
-
1991
- 1991-03-18 AU AU72995/91A patent/AU641736B2/en not_active Ceased
- 1991-03-19 CA CA002038578A patent/CA2038578C/en not_active Expired - Fee Related
- 1991-03-20 EP EP91302404A patent/EP0453097B1/en not_active Expired - Lifetime
- 1991-03-20 DE DE69115104T patent/DE69115104T2/de not_active Expired - Fee Related
- 1991-03-20 JP JP03057240A patent/JP3098050B2/ja not_active Expired - Fee Related
- 1991-03-20 ES ES91302404T patent/ES2082132T3/es not_active Expired - Lifetime
- 1991-03-20 AT AT91302404T patent/ATE131069T1/de not_active IP Right Cessation
- 1991-03-21 BR BR919101117A patent/BR9101117A/pt not_active Application Discontinuation
- 1991-03-21 IN IN83BO1991 patent/IN172885B/en unknown
Also Published As
Publication number | Publication date |
---|---|
ES2082132T3 (es) | 1996-03-16 |
DE69115104D1 (de) | 1996-01-18 |
JPH05262669A (ja) | 1993-10-12 |
JP3098050B2 (ja) | 2000-10-10 |
EP0453097B1 (en) | 1995-12-06 |
AU641736B2 (en) | 1993-09-30 |
BR9101117A (pt) | 1991-11-05 |
AU7299591A (en) | 1991-10-03 |
CA2038578C (en) | 2000-11-21 |
CA2038578A1 (en) | 1991-09-22 |
ATE131069T1 (de) | 1995-12-15 |
EP0453097A2 (en) | 1991-10-23 |
EP0453097A3 (en) | 1991-10-30 |
DE69115104T2 (de) | 1996-05-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1378525A3 (en) | Humanized antibodies that bind to the antigen bound by antibody NR-LU-13 and their use in pretargeting methods | |
EP1808155A3 (en) | Antibody-serum protein hybrids | |
AU2821195A (en) | Cross-reacting monoclonal antibodies specific for e-selectin and p-selectin | |
AU4643596A (en) | Chimeric antibodies comprising antigen binding sites and b and t cell epitopes | |
CA2267072A1 (en) | Reconstituted human anti-hm1.24 antibody | |
EP0880597A4 (en) | THERAPEUTIC APPLICATIONS FOR MONOCLONAL ANTIBODY 5c8 ANTI-T-BAM (ANTI-CD40-L) | |
WO1994016094A3 (en) | Recombinant anti-vla4 antibody molecules | |
PT1135498E (pt) | Variantes de anticorpos com maior afinidade de ligação em comparação com os anticorpos parentais | |
NZ503763A (en) | Antigenic compositions and vaccines comprising a high molecular weight (HMW) protein of Clamydia for therapeutic and prophylactic use | |
AU2423295A (en) | Antigen/antibody specificity exchanger | |
GB2278357B (en) | Humanised antibodies directed against A33 antigen | |
IN172885B (es) | ||
TR200102877T2 (tr) | İmmünoglobulinin kendi yüksek afinite reseptörüne bağlanmasını inhibe eden antikorlara karşı anti-idiotipik antikorlar. | |
WO1997029199A3 (en) | Prostate specific antigen peptides and uses thereof | |
EP0109434A4 (en) | IN VITRO DIAGNOSTICS METHODS USING MONOCLONAL ANTIBODIES AGAINST PROTEINS OF CONNECTIVE TISSUES. | |
AU2547995A (en) | Monoclonal antibody specific for vascular endothelial cell antigen endoglyx-1, the antigen itself, and uses thereof | |
AU7165891A (en) | Tumor-specific, cell surface-binding monoclonal antibodies | |
EP0613899A3 (en) | Cocaine derivative, its protein conjugate, cell line producing monoclonal antibodies, cell line production method and monoclonal antibodies. | |
AU4959193A (en) | High affinity, strongly neutralizing monoclonal antibodies against the CD-4 binding site of GP120 of human immunodeficiency virus | |
ZA941645B (en) | Antibodies specifically reactive against human prostate specific antigen. | |
AU2169797A (en) | Improved production of antibodies through the use of antigen antibody complexes | |
AU6596390A (en) | Monoclonal antibodies cross-reactive and cross-protective against p. aeruginosa serotypes | |
AU622548B2 (en) | Novel tumor-associated antigen, antibodies, compositions and uses therefor | |
ZA986064B (en) | Ancrod-specific monoclonal antibodies, antibody fragments, mixtures or derivatives thereof and their use. | |
FI956041A (fi) | Kompositiot ja diagnostiset menetelmät, joissa käytetään monoklonaalisia vasta-aineita CD44V6 vastaan |